One interpretation of these results, combined with the recent discovery of the pulmonary ionocyte, is that it is possible that expressing greater than wildtype CFTR levels in a small number of cells might restore defects associated with CF, including Cl− and HCO3− secretion, airway surface liquid pH, and host defense abnormalities. This evidence concerns the gene CFTR and cystic fibrosis.